Table 3 Summary of the donor counts with defined neuropsychiatric symptoms.
From: Population-scale cross-disorder atlas of the human prefrontal cortex at single-cell resolution
Neuropsychiatric symptom | Type | NPS-present | NPS-absent |
|---|---|---|---|
Group 1: Early insomnia | specific | 93 | 676 |
Group 1: Middle insomnia | specific | 73 | 694 |
Group 1: Late insomnia | specific | 91 | 682 |
Group 1: Hypersomnia | specific | 23 | 766 |
Group 1: Weight gain | specific | 41 | 761 |
Group 1: Suicidal ideations | specific | 91 | 717 |
Group 1: Delusional worthlessness | specific | 53 | 746 |
Group 1: Worthlessness | specific | 67 | 730 |
Group 1: Psychomotor retardation | specific | 88 | 723 |
Group 1: Sleep/WeightGain/Guilt/Suicide | aggregated | 316 | 519 |
Group 2: Weight loss | specific | 401 | 401 |
Group 2: Decreased appetite | specific | 415 | 386 |
Group 2: Psychomotor agitation | specific | 438 | 390 |
Group 2: Loss of energy | specific | 438 | 379 |
Group 2: Ruminations | specific | 391 | 428 |
Group 2: WeightLoss/PMA | aggregated | 678 | 160 |
Group 3: Dysphoria | specific | 410 | 408 |
Group 3: Anhedonia | specific | 357 | 454 |
Group 3: Depression: current to 2 weeks | specific | 254 | 558 |
Group 3: Depression: current to 6 months | specific | 268 | 541 |
Group 3: Depression: lifetime | specific | 251 | 528 |
Group 3: Depression/Mood | aggregated | 448 | 386 |
